What Explains Emerging Markets’ Relatively Low COVID-19 Fatality Rate? (LGIM)
Our new research suggests that emerging markets may be less vulnerable to the current crisis than previously thought.
Emerging markets have reported far fewer fatalities from COVID-19 than advanced economies at similar stages of the pandemic. Specifically, 30 days into an outbreak of the virus – measured from the day a country’s death toll surpassed 20 – emerging markets report almost 90% fewer fatalities than their developed market peers. READ MORE
Similar Posts:
- Deciphering the Frontier Market Opportunity (Lazard)
- South Korea Facing Worst Labor Market Crisis Since 1997 (Nikkei Asia)
- Which Emerging Markets May Benefit Most from the Rebound in China and the DM? (PGIM Fixed Income)
- North Asia vs South Asia: Differentiation is Key (DWS)
- The Emerging Emerging-Markets Crisis (Guggenheim Investments)
- Three Reasons We Remain Bullish on Emerging Markets Long Term (Franklin Templeton)
- No Emerging Markets Crisis According to Mark Mobius (FE Trustnet)
- Is Now the Right Time to Invest in Frontier Markets? (Portfolio Adviser)
- Frontier Markets: Attractive Valuations with Limited Correlation (Mobius Blog)
- Lazard Emerging Markets Fund Manager: Full-blown Financial Crisis in China is Unlikely (FE Trustnet)
- Tech and the Consumer have Reshaped Today’s Emerging Markets (Manulife IM)
- Asia and Emerging Markets Had the Worst Dividend Growth Rates for 1Q2014 (FE Trustnet)
- Is South Korea Crowding Your Emerging Markets Allocation? (S&P Dow Jones)
- Miners From Emerging Markets Outperform Peers From Developed Countries (PwC)
- JP Morgan’s Gartside: Currencies Now Bear the Blunt of Political Risk
Leave a Reply